| James K Coddington, MD | |
|
1010 4th St Sw, Mason City, IA 50401-2857 | |
| (641) 422-3020 | |
| (641) 422-7803 |
| Full Name | James K Coddington |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1010 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285740076 | NPI | - | NPPES |
| 12234 | Other | IA | WELLMARK |
| 0138990 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 19750 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James K Coddington, MD 621 S Illinois Ave, Suite 103, Mason City, IA 50401-5489 Ph: (641) 494-3041 | James K Coddington, MD 1010 4th St Sw, Mason City, IA 50401-2857 Ph: (641) 422-3020 |
News Archive
Physicians attending the annual meeting of the American Society of Clinical Oncology (ASCO) presented evidence that pegylated arginine deiminase (ADI-PEG 20), a novel anticancer drug that targets ASS(-) tumors, and which is being developed and manufactured by Polaris Group, was effective in inhibiting the growth of metastatic melanoma cells.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that Novartis has elected to fully exercise its current right to purchase 55,223 unregistered shares of Alnylam's common stock in accordance with the terms of the Investor Rights Agreement between Alnylam and Novartis, dated September 6, 2005.
USA Today examines several scientific breakthroughs that researchers say "could be key to reducing new HIV infections." "Doctors are hopeful not because of a single discovery, but because of a string of breakthroughs over the past two or three years, says Diane Havlir, a professor at the University of California-San Francisco," the news service writes.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, commented today on the ruling this week of a U.S. District Court blocking the federal government from funding research involving human embryonic stem cells. In issuing a preliminary injunction, the judge said it violated a law first passed in 1996 prohibiting federal money for research where a human embryo is destroyed.
The safety profile for CT colonography (CTC) is extremely favorable, particularly for the purposes of screening patients with no symptoms and when distending the colon using an automated carbon dioxide technique, a finding that goes against the higher complication rates for CTC reported by other groups, according to a new study.
› Verified 4 days ago
David H Hanson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 S Taylor Ave, Mason City, IA 50401 Phone: 641-422-7766 Fax: 641-422-7788 | |
Dr. Mahad Rayale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7000 | |
Dr. Chad M Mccambridge, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 4th St Sw, Suite 340, Mason City, IA 50401 Phone: 641-428-7766 Fax: 641-428-7788 | |
Patrick Alan Courtney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 4th St Sw Ste 240, Mason City, IA 50401 Phone: 641-428-7766 Fax: 641-428-7125 | |
Amanda Tran, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 4th St Sw Ste 340, Mason City, IA 50401 Phone: 641-428-7766 Fax: 641-428-7788 | |
Wei Song, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 S Taylor Ave, Mason City, IA 50401 Phone: 641-422-7779 | |
Dr. Arla Mcvicker, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 520 S Pierce Ave, Suite 150, Mason City, IA 50401 Phone: 641-421-8077 Fax: 641-494-5005 |